- Home
- MGY vs AXSM Comparison
MGY vs AXSM Comparison
Compare MGY & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGY
- AXSM
- Stock Information
- Founded
- MGY 2017
- AXSM 2012
- Country
- MGY United States
- AXSM United States
- Employees
- MGY N/A
- AXSM N/A
- Industry
- MGY Oil & Gas Production
- AXSM Biotechnology: Pharmaceutical Preparations
- Sector
- MGY Energy
- AXSM Health Care
- Exchange
- MGY Nasdaq
- AXSM Nasdaq
- Market Cap
- MGY 4.8B
- AXSM 4.2B
- IPO Year
- MGY 2017
- AXSM 2015
- Fundamental
- Price
- MGY $24.05
- AXSM $137.75
- Analyst Decision
- MGY Hold
- AXSM Strong Buy
- Analyst Count
- MGY 12
- AXSM 14
- Target Price
- MGY $26.90
- AXSM $158.93
- AVG Volume (30 Days)
- MGY 1.9M
- AXSM 1.1M
- Earning Date
- MGY 02-18-2025
- AXSM 02-18-2025
- Dividend Yield
- MGY 2.50%
- AXSM N/A
- EPS Growth
- MGY N/A
- AXSM N/A
- EPS
- MGY 1.94
- AXSM N/A
- Revenue
- MGY $1,315,886,000.00
- AXSM $385,693,000.00
- Revenue This Year
- MGY $8.23
- AXSM $45.18
- Revenue Next Year
- MGY $2.11
- AXSM $65.22
- P/E Ratio
- MGY $12.40
- AXSM N/A
- Revenue Growth
- MGY 7.25
- AXSM 42.53
- 52 Week Low
- MGY $21.56
- AXSM $64.11
- 52 Week High
- MGY $29.02
- AXSM $139.13
- Technical
- Relative Strength Index (RSI)
- MGY 48.60
- AXSM 74.55
- Support Level
- MGY $22.74
- AXSM $124.04
- Resistance Level
- MGY $25.42
- AXSM $130.52
- Average True Range (ATR)
- MGY 0.78
- AXSM 5.78
- MACD
- MGY 0.10
- AXSM 1.11
- Stochastic Oscillator
- MGY 48.88
- AXSM 96.07
About MGY Magnolia Oil & Gas Corporation
Magnolia Oil & Gas Corp is an independent oil and natural gas company engaged in the acquisition, development, exploration, and production of oil, natural gas, and natural gas liquid (NGL) reserves. The Company's oil and natural gas properties are located in Karnes County and the Giddings area in South Texas, where the Company targets the Eagle Ford Shale and Austin Chalk formations. Its objective is to generate stock market value over the long term through consistent organic production growth, high full-cycle operating margins, and an efficient capital program with short economic paybacks. The company's operating segment is acquisition, development, exploration, and production of oil and natural gas properties located in the United States.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.